Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. - Wikidata - awgldk - TriplyDB

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.

http://www.wikidata.org/entity/Q43047280

about

Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders The therapeutic potential of cannabis and cannabinoids Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake The role of endocannabinoids system in fatty liver disease and therapeutic potentials Liver steatosis in hepatitis C patients Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis Clinical Advancements in the Targeted Therapies against Liver Fibrosis.Medical consequences of marijuana use: a review of current literature Mechanisms of hepatic fibrogenesis Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis Hepatitis C virus induces the cannabinoid receptor 1.Role of cannabinoids in the development of fatty liver (steatosis)Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls Marijuana use in hepatitis C infection does not affect liver biopsy histology or treatment outcomes.Endocannabinoids in liver disease.Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.Cannabinoid receptor type I modulates alcohol-induced liver fibrosis.Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice Endocannabinoids and the control of energy homeostasis.Metabolic effects of chronic cannabis smoking Molecular mechanisms of alcoholic fatty liver Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis.Liver Illness and Psychiatric Patients.Pathophysiology of NASH: perspectives for a targeted treatment.Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.Update on the pathophysiology of liver fibrosis.Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?New therapeutic paradigm for patients with cirrhosis.Cannabinoid 1 receptor in fatty liver.Review article: the endocannabinoid system in liver disease, a potential therapeutic target.Medical marijuana for digestive disorders: high time to prescribe?Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs.Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.

P2860

Q22299116-4269B245-3BDD-4C37-9889-6454E7DB7560 Q24600806-649AEC4D-B937-4D9A-AA22-CAAE2FA11907 Q26827517-5AED9260-7906-4C02-8D6C-77279EEDAFBD Q26850858-E4A82800-9B61-4F01-B2B2-6A9AA49E2AA8 Q27009466-C3AC523F-EA20-457B-BF15-4C40E910F245 Q27010631-D2AC6B40-8DF0-4307-A314-73311078287B Q27021577-9A600B6D-E440-4B9C-A375-0CBB636E2299 Q28078684-E37763A5-CF62-406D-8608-C726D1F5317C Q28301998-2225C645-2485-4BE3-85BC-AF2550BBA4AF Q29619336-A4DEDD76-B041-4D17-9A32-6A3B2C33D313 Q30429470-0000C4B4-E625-4759-9EC2-4046AF27C9A5 Q33464957-2C75DC5B-8453-4732-9685-C2AA6652B5C1 Q33700418-2DD5D0F6-D9D2-4A30-BE34-6681E6C7342B Q33749478-C157EEEC-AA03-4F62-A517-2B96E048DF0F Q34022349-EDC464B0-566F-4281-AEB5-27FDC08809F5 Q34088634-2559E503-4775-4E33-B0CE-9665FC3D2ECE Q34776919-09562FD0-E854-43E3-95F4-5DD16F9E9444 Q34873114-11688C55-6959-4AD2-B069-7FF0A870A977 Q35193292-1A67F856-899B-44E0-A806-299E615FA0F1 Q35585455-E974336D-7D70-496D-AA43-DF644115D6AA Q35876795-AA417AA7-DD80-4183-A0B9-97EECCDD329A Q36026554-41DA9E12-A7CE-46ED-8AA4-5C78CCEDCCE8 Q36800423-57D9BFD3-9CDC-4B05-89F3-41FADFB59BEB Q36981004-28F538A9-180F-4177-8137-3FFB0D834321 Q37022702-A5BEEF7D-D3F2-4B1F-BBA0-5469052C3E45 Q37078754-7A42286E-3B58-4344-BAC5-1ACD7BD7B227 Q37085008-EF6354B6-E759-490F-8FB8-F86C6778A6D1 Q37091495-9801545A-BB11-40B0-9FAA-BCF63DCFABF9 Q37587062-68ED2DE7-49B0-4ED7-A6F0-5390D179C4C3 Q37699476-E8CE6EEC-9A4A-45BB-916E-57CB50C09CA5 Q37772959-CD637D4A-3BCD-47E4-8BF5-FDF52668F87A Q37777155-CAA67E8C-1CC8-46D0-AEFF-B1635D6F74BB Q37863141-A32AF1D9-D155-4882-87E5-4FF04AA2CEE6 Q38021413-5C83161E-3DE1-489E-ABA3-EE0F817FEDB8 Q38044956-56314AA4-9292-4352-927E-5588E2572379 Q38194626-9C0C6F16-FF19-44F2-B5A3-0C8EAB46058D Q38246940-4C1581E5-2183-49E0-9112-99618DA66A23 Q38503842-FFC538D0-A875-4765-98C1-ABF50956F515 Q38710078-808BC81F-394B-4364-AAB4-E2661C210D82 Q38826862-5D27EBB3-E9C8-4490-B4CA-9F7A74D0D91F

P2860

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.

http://www.wikidata.org/entity/Q43047280

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Daily cannabis use: a novel ri ...... ents with chronic hepatitis C.

@en

Daily cannabis use: a novel ri ...... ents with chronic hepatitis C.

@nl

type

label

Daily cannabis use: a novel ri ...... ents with chronic hepatitis C.

@en

Daily cannabis use: a novel ri ...... ents with chronic hepatitis C.

@nl

prefLabel

Daily cannabis use: a novel ri ...... ents with chronic hepatitis C.

@en

Daily cannabis use: a novel ri ...... ents with chronic hepatitis C.

@nl

P1433

Q43047280-91F4F83D-412D-41CF-8D1F-9DFB25E35FED

P1476

Q43047280-1C5A519F-CC3F-4BD9-81E8-6363A24A7A9D

P2093

Q43047280-325D1C69-7E44-4F5A-B0F6-CC6B345738F5

Q43047280-41C81EE6-B4CB-4E52-AEFC-3F85708557CE

Q43047280-61257F44-F0E8-46FB-8AA7-AF79548702CA

Q43047280-75AD65CD-521E-4FC0-A122-5C25D3FBA187

Q43047280-856CED34-5918-4482-B4BE-4C2F75CF627D

Q43047280-88329ACB-4786-47D5-B207-C8BE60474A2B

Q43047280-8FA41245-8FAD-49FC-BFB4-0803EA1E3992

Q43047280-C78B31A6-09F2-41F5-86AA-FC8AA2CE56C5

Q43047280-D2640063-FA6C-4233-8873-6071562111BE

P304

Q43047280-9315201D-0D0F-4518-A7FE-A24138A4BF04

P31

Q43047280-108639DD-BCE7-4EAF-A0EE-E1C969D32B28

P356

Q43047280-115409B0-C419-4022-9D58-F1F46444C111

P407

Q43047280-31CF767D-1B25-4750-AC9A-16989CEEE98D

P433

Q43047280-4CA41514-F89B-494D-A804-3CE6B547F07A

P478

Q43047280-D8D8BAAD-3B45-488C-94B9-84E327E40A70

P50

Q43047280-01E8A285-DD7E-4064-B9A1-0C6948046B6F

Q43047280-02F2EBE9-8129-41C1-B1A2-19448D0A8390

Q43047280-1A5EF5F7-1913-4240-A132-E526BE23B1F7

Q43047280-5C4AE420-FB80-4F2F-A5D4-545EED4C6576

Q43047280-B6AF02AD-DFFB-4BA9-8604-996595EEC088

P577

Q43047280-05863F7E-1202-4374-9441-87E9538FECC9

P698

Q43047280-3971DC19-737A-4FF5-B0DA-C4854AB11855

P921

Q43047280-0CBA71AD-181F-42CD-8900-92BD24F42459

P356

J.GASTRO.2007.11.039

P1433

Gastroenterology

P1476

Daily cannabis use: a novel ri ...... ents with chronic hepatitis C.

@en

P2093

Ali Hessami

http://www.w3.org/2001/XMLSchema#string

Ariane Mallat

http://www.w3.org/2001/XMLSchema#string

Charlotte Costentin

http://www.w3.org/2001/XMLSchema#string

Christophe Hézode

http://www.w3.org/2001/XMLSchema#string

Elie Serge Zafrani

http://www.w3.org/2001/XMLSchema#string

Fatiha Medkour

http://www.w3.org/2001/XMLSchema#string

Françoise Roudot-Thoraval

http://www.w3.org/2001/XMLSchema#string

Jean-Michel Pawlostky

http://www.w3.org/2001/XMLSchema#string

Magali Bouvier-Alias

http://www.w3.org/2001/XMLSchema#string

P304

432-439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2007.11.039

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

Christophe Hézode

Magali Bouvier-Alias

Sophie Lotersztajn

Françoise Roudot-Thoraval

Sophie Lotersztajn

P577

2007-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18242211

http://www.w3.org/2001/XMLSchema#string

P921